#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lennox-Gastaut syndrome Chronic myeloid leukaemia (in remission) Cutaneous T-cell lymphoma refractory Neutropenia Fragile X syndrome Toxic epidermal necrolysis Leukoencephalopathy Langerhans' cell histiocytosis Oesophageal atresia Epileptic encephalopathy Pulmonary arterial hypertension Metachromatic leukodystrophy Crigler-Najjar syndrome Stiff person syndrome Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Lymphatic malformation – Diagnostics Mantle cell lymphoma stage III – Life with Disease Mantle cell lymphoma stage II – Diagnostics Marginal zone lymphoma refractory Von Willebrand’s disease – Life with Disease Wolfram syndrome – Trials in Disease Osteosarcoma metastatic – Treatment Uterine leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pentixafor HEMOPEXIN, HUMAN Tak-280 Mycophenolic Acid Ro7790121 Naporafenib ZELENECTIDE PEVEDOTIN Eliglustat Tartrate Emicizumab Mepivacaine Hydrochloride Amiodarone Hydrochloride Cd7-Cart01 Dorzolamide Gskvx000000008866 HUPERZINE A Zoledronic Acid Levocetirizine Dihydrochloride Pemigatinib [14C]ZIPALERTINIB Amylase More therapies…

    Learn about Your Condition

    Myopia Von Hippel-Lindau disease Myxoid liposarcoma Hypoxia Colonoscopy Desmoplastic melanoma Papilloma viral infection EGFR gene mutation Lichen sclerosus Tendon rupture Deafness traumatic Perinatal depression Cholangitis sclerosing Haemorrhage intracranial Urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Human Normal Immunoglobulin to Prevent BKV Infection in Kidney Transplant Patients with Low Antibody Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Human Normal Immunoglobulin
    France

  • Study on the Safety and Effectiveness of a Dendritic Cell Vaccine and Temozolomide for Patients with Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Temozolomide
    Italy

  • Study on HIV-1 Patients: Effects of Rilpivirine and Dolutegravir After Stopping Antiretroviral Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir
    • Rilpivirine
    Italy

  • Study comparing Dry Needling and Botulinum Toxin Type A treatments for leg muscle stiffness in stroke patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium Spain

  • Study on the Effectiveness and Safety of Betaine Citrate for Treating Functional Dyspepsia in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • Betaine Citrate
    Greece

  • Study on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Riliprubart
    Belgium Czechia Denmark France Germany Greece +7
Previous Page
1 … 526 527 528 529 530 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!